| Annual Financials | 2024 | 2025 | TTM |
Revenue  | 62 | 86 | 0 |
| Expenses | 55 | 71 | 0 |
| EBITDA | 7 | 15 | 0 |
| Operating Profit % | 10 % | 16 % | 0 % |
| Depreciation | 1 | 1 | 0 |
| Interest | 3 | 4 | 0 |
| Profit Before Tax | 3 | 10 | 0 |
| Tax | 1 | 3 | 0 |
| Net Profit | 2 | 8 | 0 |
| EPS in ₹ | 1.90 | 6.64 | 0.00 |
Neochem Bio Solutions
Neochem Bio Solutions
95.05
-4.10
(-4.14%)
Market Cap
162.73 Cr
PE Ratio
21.89
Volume
16,800.00
Day High - Low
99.50 - 95.00
52W High-Low
121.00 - 63.00
Key Fundamentals
Market Cap
162.73 Cr
EPS
6.64
PE Ratio
21.89
PB Ratio
2.37
Book Value
41.89
EBITDA
15.10
Dividend Yield
0.00 %
Industry
Chemicals Sector
Specialty Chemicals Return on Equity
39.24
Debt to Equity
2.17
Actual
Company News
View All News
Neochem Bio Solutions Limited reported a 32% rise in FY26 revenue to INR110.7 crore. PAT grew 62% to INR12 crore with EBITDA margins expanding to 20.4%.
Neochem Bio FY26 PAT rises 62%
May 19, 2026
May 19, 2026Neochem Bio Solutions reported a 62% YoY rise in PAT to ₹1,203 lakh for FY26. Revenue grew 32% to ₹11,069 lakh.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,469.20 | #1 1,49,530.22 | 59.91 | 14,600.80 | 9.06 | #1 2,474 | 36.65 | 57.09 | |
2,718.40 | 80,580.12 | 44.38 | #1 15,416.40 | 3.98 | 1,835 | 10.63 | 56.24 | |
3,642.90 | 40,017.26 | 70.00 | 4,996.00 | 2.94 | 569 | -42.93 | 50.33 | |
7,035.50 | 36,044.26 | 54.54 | 3,313.90 | 38.48 | 664 | #1 123.79 | 53.77 | |
602.05 | 30,375.93 | 40.65 | 4,832.00 | 3.60 | 755 | 33.44 | 57.53 | |
1,698.90 | 23,171.81 | 41.69 | 7,887.07 | -5.72 | 566 | 8.54 | 46.89 | |
6,655.50 | 19,594.96 | #1 28.35 | 6,273.54 | 10.21 | 729 | 62.26 | 41.27 | |
463.80 | 16,817.13 | 40.61 | 8,286.00 | 13.73 | 365 | 42.71 | 46.13 | |
1,139.40 | 15,116.92 | 66.33 | 1,160.14 | 31.79 | 240 | 7.36 | 53.33 | |
1,327.20 | 15,109.95 | 67.99 | 2,365.46 | #1 63.30 | 203 | -10.97 | 45.89 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
39.03 %
Net Income Growth
333.33 %
Cash Flow Change
32.14 %
ROE
161.43 %
ROCE
117.68 %
EBITDA Margin (Avg.)
58.55 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 |
| Total Assets | 64 | 79 |
| Fixed Assets | 19 | 19 |
| Current Assets | 39 | 53 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 45 | 60 |
| Total Equity & Liabilities | 64 | 79 |
| Current Liabilities | 33 | 44 |
| Non Current Liabilities | 19 | 15 |
| Total Equity | 12 | 20 |
| Reserve & Surplus | 5 | 13 |
| Share Capital | 7 | 7 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | -0 |
| Investing Activities | -3 | -8 | -2 |
| Operating Activities | -1 | 2 | 3 |
| Financing Activities | 4 | 6 | -1 |
Share Holding
| % Holding | Aug 2025 | Nov 2025 | Dec 2025 | Mar 2026 |
| Promoter | 91.12 % | 91.12 % | 91.12 % | 66.72 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.18 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 15.82 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 0.00 % | 10.93 % |
| Others | 8.88 % | 8.88 % | 8.88 % | 6.35 % |
| No of Share Holders | 14 | 14 | 14 | 406 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 May 2026 |  Quarterly Result Announcement | NA | 18 May 2026 | 86.60 | 93.60 |
Technical Indicators
RSI(14)
Neutral 55.69
ATR(14)
Less Volatile 7.82
STOCH(9,6)
Neutral 54.41
STOCH RSI(14)
Oversold 4.75
MACD(12,26)
Bearish -0.09
ADX(14)
Strong Trend 31.90
UO(9)
Bearish 48.12
ROC(12)
Uptrend And Accelerating 13.57
WillR(14)
Neutral -56.98
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
